Our group is focused on the development and validation of methods for Cancer Imaging, mostly by MRI. Of particular interest to us is the tumour micro-environment and associated tissue heterogeneity. Our experimental techniques include dynamic-contrast-enhanced MRI, diffusion-weighted MRI, dynamic susceptibility-weighted imaging and MR spectroscopy. We use these techniques in clinical (imaging) trials and in pre-clinical research on tumour models. The objective of our work is the identification of imaging biomarkers that can be used clinically for the detection of cancer and monitoring of treatment. An important aspect of this effort is the validation of imaging biomarkers through the use of co-registered histological mapping.

• Quantifying Information from Dynamic Contrast-Enhanced MRI
  • The Role of an Arterial Input Function
  • T1 Quantifications at DCE Baseline in 3D and 2D acquisitions in the presence of B1 inhomogeneities
• Linking histpathology with MRI: Distribution of Trastuzumab in Breast Cancer
• Contrast Agents in MRI of tumours
• Radiation Treatment Monitoring in Brain Tumours

Our offices are in

Hennings Building
6224 Agricultural Rd.
Vancouver, B.C.
Canada V6T 1Z1

Our experiment are performed at the UBC High-Field MRI Research Centre as well as the MRI scanner of the BC Cancer Agency.